Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Fardel

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Toxicology|November 25, 2000
Expression and regulation of hepatic drug and bile acid transportersV Lecureur, A Courtois, L Payen, et al.
Anticancer Research|July 1, 1994
Conformational changes in membrane proteins of multidrug-resistant K562 and primary rat hepatocyte cultures as studied by Fourier transform infrared spectroscopyJ M Le Gal, H Morjani, O Fardel, et al.
Leukemia Research|April 1, 1994
Transport and metabolism of polyamines in wild and multidrug resistant human leukemia (K 562) cellsN A Khan, O Fardel, R Havouis, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 24, 2010
Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier modelB Joly, O Fardel, R Cecchelli, et al.
International Journal of Oncology|May 10, 2011
Expression of p-glycoprotein in multidrug-resistant human leukemia k562 cells during erythroid-differentiationO Fardel, F Escande, B Rault, et al.
Carcinogenesis|December 11, 1999
Differential regulation of canalicular multispecific organic anion transporter (cMOAT) expression by the chemopreventive agent oltipraz in primary rat hepatocytes and in rat liverA Courtois, L Payen, L Vernhet, et al.
British Journal of Pharmacology|February 13, 2001
The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cellsL Payen, L Delugin, A Courtois, et al.
Cell Biology and Toxicology|September 11, 2002
The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compoundsL Payen, L Sparfel, A Courtois, et al.
Biochemical Pharmacology|May 2, 2001
Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxideL Vernhet, N Allain, L Payen, et al.
International Journal of Oncology|July 31, 1999
Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activityB Laupeze, L Amiot, A Courtois, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Toxicology|November 25, 2000
Expression and regulation of hepatic drug and bile acid transportersV Lecureur, A Courtois, L Payen, et al.
Anticancer Research|July 1, 1994
Conformational changes in membrane proteins of multidrug-resistant K562 and primary rat hepatocyte cultures as studied by Fourier transform infrared spectroscopyJ M Le Gal, H Morjani, O Fardel, et al.
Leukemia Research|April 1, 1994
Transport and metabolism of polyamines in wild and multidrug resistant human leukemia (K 562) cellsN A Khan, O Fardel, R Havouis, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 24, 2010
Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier modelB Joly, O Fardel, R Cecchelli, et al.
International Journal of Oncology|May 10, 2011
Expression of p-glycoprotein in multidrug-resistant human leukemia k562 cells during erythroid-differentiationO Fardel, F Escande, B Rault, et al.
Carcinogenesis|December 11, 1999
Differential regulation of canalicular multispecific organic anion transporter (cMOAT) expression by the chemopreventive agent oltipraz in primary rat hepatocytes and in rat liverA Courtois, L Payen, L Vernhet, et al.
British Journal of Pharmacology|February 13, 2001
The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cellsL Payen, L Delugin, A Courtois, et al.
Cell Biology and Toxicology|September 11, 2002
The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compoundsL Payen, L Sparfel, A Courtois, et al.
Biochemical Pharmacology|May 2, 2001
Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxideL Vernhet, N Allain, L Payen, et al.
International Journal of Oncology|July 31, 1999
Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activityB Laupeze, L Amiot, A Courtois, et al.
Pageof 7